UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Questcor Pharmaceuticals, Inc.
(formerly Cypros Pharmaceuticals Corporation)
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, No Par Value
- --------------------------------------------------------------------------------
(Title of Class of Securities)
232808105
- --------------------------------------------------------------------------------
(CUSIP Number)
April 5, 2001
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
/ / Rule 13d-1(b)
/X/ Rule 13d-1(c)
/ / Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP 232808105 SCHEDULE 13G -2-
- --------------------------------------------------------------------------------
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Sigma-Tau Finanziaria SpA
- --------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group
(See Instructions) (a) / /
(b) / /
- --------------------------------------------------------------------------------
3. SEC Use Only
- --------------------------------------------------------------------------------
4. Citizenship or Place of Organization
Italy
- --------------------------------------------------------------------------------
5. Sole Voting Power
5,747,126
-----------------------------------------------------
Number of 6. Shared Voting Power
Shares
Beneficially 0
Owned by Each ----------------------------------------------------
Reporting 7. Sole Dispositive Power
Person With:
5,747,126
-----------------------------------------------------
8. Shared Dispositive Power
0
- --------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
5,747,126
- --------------------------------------------------------------------------------
10. Check box if the Aggregate Amount in Row (9) Excludes
Certain Shares (See Instructions) / /
- --------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9)
18.5%
- --------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions)
CO
CUSIP 232808105 SCHEDULE 13G -3-
- --------------------------------------------------------------------------------
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Sigma-Tau Finance Holding S.A.
- --------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group
(See Instructions) (a) / /
(b) / /
- --------------------------------------------------------------------------------
3. SEC Use Only
- --------------------------------------------------------------------------------
4. Citizenship or Place of Organization
Luxembourg
- --------------------------------------------------------------------------------
5. Sole Voting Power
5,747,126
-----------------------------------------------------
Number of 6. Shared Voting Power
Shares
Beneficially 0
Owned by Each -----------------------------------------------------
Reporting 7. Sole Dispositive Power
Person With:
5,747,126
-----------------------------------------------------
8. Shared Dispositive Power
0
- --------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
5,747,126
- --------------------------------------------------------------------------------
10. Check box if the Aggregate Amount in Row (9) Excludes
Certain Shares (See Instructions) / /
- --------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9)
18.5%
- --------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions)
CO
CUSIP 232808105 SCHEDULE 13G -4-
Item 1(a). Name of Issuer:
Questcor Pharmaceuticals, Inc. (formerly Cypros Pharmaceuticals
Corporation) ("Questcor").
Item 1(b). Address of Issuer's Principal Executive Offices:
26118 Research Road
Hayward, CA 94545
Item 2(a). Name of Person Filing:
This statement is filed on behalf of each of the following persons
(collectively, the "Reporting Persons")
(1) Sigma-Tau Finanziaria SpA ("Sigma-Tau")
(2) Sigma-Tau Finance Holding S.A., a wholly owned subsidiary of
Sigma-Tau ("Holding").
Item 2(b). Address of Principal Business Office:
(1)
Sigma-Tau
Via Sudafrica, 20
00144 Rome
Italy
(2)
Holding
Via Sudafrica, 20
00144 Rome
Italy
Item 2(c). Citizenship:
(1) Sigma-Tau is an Italian corporation.
(2) Holding is a Luxembourg corporation.
Item 2(d). Title of Class of Securities:
Common Stock, no par value (the "Shares")
Item 2(e). CUSIP Number:
232808105
Item 3. If this statement is filed pursuant to ss.ss.240.13d-1(b) or
240.13d-2(b) or (c), check whether the person is a:
This Item 3 is not applicable
CUSIP 232808105 SCHEDULE 13G -5-
Item 4. Ownership:
(1) Sigma-Tau
(a) Amount beneficially owned: 5,747,126(1)(2)
(b) Percent of class: 18.5%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct
the vote: 5,747,126
(ii) shared power to vote or to direct
the vote: 0
(iii) sole power to dispose or to direct
the disposition of: 5,747,126
(iv) shared power to dispose or to direct
the disposition of: 0
(2) Holding
(a) Amount beneficially owned: 5,747,126(1)(2)
(b) Percent of class: 18.5%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct
the vote: 5,747,126
(ii) shared power to vote or to direct
the vote: 0
(iii) sole power to dispose or to direct
the disposition of: 5,747,126
(iv) shared power to dispose or to direct
the disposition of: 0
---------
(1): All of the Shares are held by Holding and are restricted shares
subject to certain limitations on resale.
(2): 2,873,563 of the Shares beneficially owned are issuable upon exercise
of a Warrant held by Holding, however, Holding may not exercise the
warrant for greater than 2,161,752 shares unless Questcor has received
shareholder approval in compliance with the rules and regulations of the
American Stock Exchange.
Item 5. Ownership of Five Percent or Less of a Class:
Not Applicable
Item 6. Ownership of More than Five Percent on Behalf of Another Person:
Not Applicable
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company:
Not Applicable
Item 8. Identification and Classification of Members of the Group:
CUSIP 232808105 SCHEDULE 13G -6-
Not Applicable
Item 9. Notice of Dissolution of Group:
Not Applicable
Item 10. Certification:
By signing below, I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not
held for the purpose of or with the effect of changing or influencing
the control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any transaction
having that purpose or effect.
CUSIP 232808105 SCHEDULE 13G -7-
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Dated: April 9, 2001
SIGMA TAU FINANZIARIA SPA
By: /s/ Paolo Cavazza
----------------------------------------------
Name: Paolo Cavazza
Title: Vice President and Managing Director
SIGMA TAU FINANCE HOLDING S.A.
By: /s/ Antonio Nicolai
----------------------------------------------
Name: Antonio Nicolai
Title: Director
CUSIP 232808105 SCHEDULE 13G -8-
EXHIBIT INDEX
Page No.
A. Joint Filing Agreement dated April 9, 2001 by and among Sigma Tau
Finanziaria SpA and Sigma Tau Finance Holding
S.A..............................................................
EXHIBIT A
JOINT FILING AGREEMENT
The undersigned hereby agree that the statement on Schedule 13G with
respect to the Common Stock of Questcor Pharmaceuticals, Inc. dated as of April
9, 2001 is, and any amendments thereto (including amendments on each of us
pursuant to and in accordance with the provisions of Rule 13d-1(f) under the
Securities Exchange Act of 1934).
Dated: April 9, 2001
SIGMA TAU FINANZIARIA SPA
By: /s/ Paolo Cavazza
---------------------------
Name: Paolo Cavazza
Title: Vice President and
Managing Director
SIGMA TAU FINANCE HOLDING SA
By: /s/ Antonio Nicolai
--------------------------
Name: Antonio Nicolai
Title: Director